Stroke Trial, Recruiting (NCT05638464)

Stroke Trial, Recruiting NCT05638464 Sponsor: Chinese University of Hong Kong Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05638464 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had their first-ever stroke, where more than 12 months have passed since it occurred
People with mild to moderate weakness or movement difficulty in the upper arm and hand, based on a specific movement assessment score (between 15 and 53 on the Fugl-Meyer Upper Extremity scale)
People whose finger flexor and extensor muscles still produce a detectable electrical signal when they try to move voluntarily
People with a muscle stiffness score below 3 (on the Modified Ashworth Scale) in the finger flexor and extensor muscles
People with sufficient thinking and memory ability to follow instructions during the study, based on a standard cognitive test score above 21 (Mini Mental State Examination)

Who may not be able to join:

People with a history of epilepsy, or any other condition that would make brain stimulation unsafe for them
People with severe joint stiffness or tightening in the elbow or shoulder, or pain caused by other neurological, neuromuscular, or bone and joint conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raymond Kai-yu Tong, PhD, Department of Biomedical Engineering, CUHK

Phone: +852 3943 8454

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05638464

Sponsor: Chinese University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +852 3943 8454

More information: https://clinicaltrials.gov/study/NCT05638464

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had their first-ever stroke, where more than 12 months have passed since it occurred
People with mild to moderate weakness or movement difficulty in the upper arm and hand, based on a specific movement assessment score (between 15 and 53 on the Fugl-Meyer Upper Extremity scale)
People whose finger flexor and extensor muscles still produce a detectable electrical signal when they try to move voluntarily
People with a muscle stiffness score below 3 (on the Modified Ashworth Scale) in the finger flexor and extensor muscles
People with sufficient thinking and memory ability to follow instructions during the study, based on a standard cognitive test score above 21 (Mini Mental State Examination)

Who may not be able to join:

People with a history of epilepsy, or any other condition that would make brain stimulation unsafe for them
People with severe joint stiffness or tightening in the elbow or shoulder, or pain caused by other neurological, neuromuscular, or bone and joint conditions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

13 August 2021

Est. completion

1 December 2024

Where this trial is recruiting

Hong Kong

Primary endpoints

Fugl-Meyer Assessment Upper Extremity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov